Subscribe Log in

Log in

Remember me. [?]
Forgotten password
Not got an account?

Subscribe or register here

Toggle navigation
Student BMJ
Search
  • News & views
    • At a glance >>
    • Life
    • Briefings
    • Research explained
    • Views
    • People
  • Clinical
    • Practical skills
    • Clinical reviews
    • Ethics & law
    • Picture quizzes
    • Junior doctor survival kit
  • Specialties
    • Cardiology
    • Emergency medicine
    • Gastroenterology
    • General practice
    • General Surgery
    • Geriatric medicine
    • Neurology
    • Obstetrics & Gynaecology
    • Paediatrics
    • Psychiatry
    • Radiology
    • Respiratory
  • Careers
    • Career planning
    • A career in...
    • Electives
    • Foundation programme
    • Careers advice
  • Applying to medical school
    • At a glance >>
    • Application timeline
    • Considering medicine
    • Medical School Selector
    • Work experience
    • Personal statement
    • Entrance exams
    • Interviews
    • Plan B
    • Graduate entry medicine
    • Mediprep course
  • Subscribe

Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. A retrospective cohort study

Does breast cancer screening work?

By: Nick Dunn

All screening programmes tend to be somewhat controversial on the grounds of expense, logistics, and clinical value, but breast cancer screening is particularly so. The mammography programme for breast cancer screening, introduced to most Western countries during the 1980s and 1990s, has generated much debate over its efficacy. One difficulty is that the assessment of screening programmes cannot always incorporate trend changes in the incidence of breast cancer. Screening results are another concern—changes in the types of treatment offered, because of clinical advances, can make such results difficult to interpret. Furthermore, the outcomes that screening programmes choose to measure can vary; for example, whether mortality rates or mastectomy rates are the primary outcome. Not all suspicious lesions identified on mammography are premalignant or malignant, and even biopsied and confirmed cancerous lesions might regress spontaneously. These effects could lead to considerable overtreatment.1

Although several studies have investigated mortality from breast cancer

To read the rest of this article log in or subscribe to Student BMJ.

If you're not ready to subscribe yet you can access News & views for free or register with us to receive free updates on our latest content.

Log in Subscribe
  • Most viewed
  • What's new

Stay in touch

  • Register for email alerts

Contact us

  • Contact us
  • Advertisers and sponsors
  • Media

About Student BMJ

  • About us
  • Join the BMA
  • Subscribe
  • Write for Student BMJ
  • Review articles for Student BMJ
  • The BMJ
  • The Student BMJ scholarship
  • Request permissions
  • Sitemap

Terms and Conditions

  • Website T&Cs
  • Medical School Selector T&Cs
  • Privacy policy

© BMJ Publishing Group Limited 2018. All rights reserved.